FDA approved betrixaban (BEVYXXA, Portola) for the prophylaxis of venous thromboembolism (VTE) in adult patients

Trial

APEX

Drug

BEVYXXA (betrixaban) · Factor Xa inhibitor

Condition

Classical hematology